To further explore whether PI3K-AKT signaling was related to NF-κB P65, IκBα and IKKβ signaling in cervical cancer, we tested the expression changes of these signaling molecules after cervical cancer cells were treated with PI3K inhibitor LY294002 and AKT-shRNA vector. This evidence concerns the gene IKBKB and cervical cancer.